Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Groupe SYNERLAB CDMO is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:France
Founded:1996
Employees:1,975
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Global
Manufacturing Facilities
1 site worldwide
MERIBEL PHARMA PROVENCE
ZA DE LA GANDONNE RUE DU REMOULAIRE, SALON DE PROVENCE, 13300
Site Capabilities
1 capabilityAPI MANUFACTURE
Regulatory Approvals
Drug Approval 66V8WY
PMDA · #APR-YD8HL3K3 · 2019-05-01
Drug Approval QGPDJ0
Health Canada · #APR-7BCNEO4S · 2020-11-01
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-3DATIYAR
Issued: 2020-04-16
Expires: 2025-01-13
Health Canada GMP
Health Canada
Cert #: CERT-HVLGLE76
Issued: 2020-01-10
Expires: 2025-12-03
Loading CDMO intelligence...
Key facts about Groupe SYNERLAB CDMO
- Groupe SYNERLAB CDMO is headquartered in France.
- Groupe SYNERLAB CDMO was founded in 1996.
- Groupe SYNERLAB CDMO has 1,975 employees.
- Groupe SYNERLAB CDMO has one manufacturing site listed on CDMO Hub, in SALON DE PROVENCE, France.
- Groupe SYNERLAB CDMO's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Groupe SYNERLAB CDMO
Directory pages this company appears in, each with the full list of matching manufacturers.